Lonza Group AG (SWX: LONN)
Health Care · Life Sciences Tools & Services · CH
CHF593.80
+1.02% today · +3.7% 1Y
Lonza Group AG (SWX: LONN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $51.65B and employs 20,141 people.
Over the last twelve months the share price has gained 3.7%, trading between 454.60 and 594.00.
Tweenvest scores Lonza Group AG across four factors: quality 68/100, value 43/100, growth 49/100, dividend 70/100. Its strongest factor is dividend.
LONN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $51.65B
- Revenue (TTM)
- $8.50B
- P/E
- 38.38
- EPS
- -1.57
- Dividend yield
- 0.85%
- Beta (5Y)
- 0.84
- 52-week high
- CHF594.00
- 52-week low
- CHF454.60
- Avg volume (3M)
- —
- Shares outstanding
- 69.84M
- Employees
- 20,141
- Next earnings
- —
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
- ISIN
- CH0013841017
- Founded
- 1897
- Listed since
- Nov 1, 1999
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.97 | +0.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.77 | +0.87% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $259.42 | -0.32% |
| Waters CorporationNYSE: WAT | $40.72B | $414.44 | +0.90% |
| Illumina, Inc.NasdaqGS: ILMN | $33.97B | $224.99 | +0.79% |
Figures last refreshed Aug 18, 2026.